Literature DB >> 23917361

Paraganglioma of urinary bladder.

Azhar Ali Malik1, Bachar Afandi, Gohar Jamil, Syed M J Akhter.   

Abstract

Paraganglioma of the urinary bladder is extremely rare. In this report of a young man, hypertensive crisis and ventricular arrhythmia was provoked during cystoscopic evaluation of a bladder mass. A diagnosis of pheochromocytoma was considered following detection of high serum and urinary catecholamine levels. A preoperative meta-iodobenzylguanidine scan was, however, negative. The bladder mass was surgically removed following initiation of antihypertensive therapy. Pathological confirmation of extraadrenal pheochromocytoma was established. During a serial follow-up, serum and urine catecholamine levels were persistently elevated. This was explained by abnormalities on fluorodeoxyglucose positron emission tomography scan, which were considered to represent a metastatic malignant neuroendocrine tumour. The patient is on palliative chemotherapy for malignant paraganglioma. This case highlights variable presentation of pheochromocytoma, importance of having a high index of clinical suspicion for early recognition and prompt management and serious adverse consequence of a delayed diagnosis.

Entities:  

Mesh:

Year:  2013        PMID: 23917361      PMCID: PMC3761672          DOI: 10.1136/bcr-2013-010063

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Clinical experience over 48 years with pheochromocytoma.

Authors:  R E Goldstein; J A O'Neill; G W Holcomb; W M Morgan; W W Neblett; J A Oates; N Brown; J Nadeau; B Smith; D L Page; N N Abumrad; H W Scott
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

Review 2.  Clinical review 164: The laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience.

Authors:  Yogish C Kudva; Anna M Sawka; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

3.  Pheochromocytoma of the urinary bladder.

Authors:  I J ZIMMERMAN; R E BIRON; H E MACMAHON
Journal:  N Engl J Med       Date:  1953-07-02       Impact factor: 91.245

Review 4.  Imaging evaluation of the non-functioning indeterminate adrenal mass.

Authors:  A Sahdev; R H Reznek
Journal:  Trends Endocrinol Metab       Date:  2004-08       Impact factor: 12.015

5.  Clinical spectrum and outcome of functional extraadrenal paraganglioma.

Authors:  D S O'Riordain; W F Young; C S Grant; J A Carney; J A van Heerden
Journal:  World J Surg       Date:  1996-09       Impact factor: 3.352

6.  The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma.

Authors:  C G Perry; A M Sawka; R Singh; L Thabane; J Bajnarek; W F Young
Journal:  Clin Endocrinol (Oxf)       Date:  2007-03-27       Impact factor: 3.478

7.  Changes in urinary total metanephrine excretion in recurrent and malignant pheochromocytomas and secreting paragangliomas.

Authors:  Laurence Amar; Séverine Peyrard; Patrick Rossignol; Franck Zinzindohoue; Anne-Paule Gimenez-Roqueplo; Pierre-François Plouin
Journal:  Ann N Y Acad Sci       Date:  2006-08       Impact factor: 5.691

8.  A 15-year experience with chemotherapy of patients with paraganglioma.

Authors:  S R Patel; D J Winchester; R S Benjamin
Journal:  Cancer       Date:  1995-10-15       Impact factor: 6.860

9.  Pheochromocytoma: state-of-the-art and future prospects.

Authors:  Emmanuel L Bravo; Rodrigo Tagle
Journal:  Endocr Rev       Date:  2003-08       Impact factor: 19.871

10.  Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients.

Authors:  Hui Huang; Jame Abraham; Elizabeth Hung; Steven Averbuch; Maria Merino; Seth M Steinberg; Karel Pacak; Tito Fojo
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.921

View more
  1 in total

1.  Bladder Paraganglioma: Three Cases Report and Literature Review.

Authors:  Yaoji Yuan; Zhengming Su; Rui Zhu; Xiezhao Li; Guibin Xu
Journal:  Int Med Case Rep J       Date:  2021-11-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.